$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function 원문보기

International journal of molecular sciences, v.18 no.4, 2017년, pp.846 -   

Kim, Jeongjun (Department of Biomedical Engineering, Mokwon University, Daejeon 35349, Korea) ,  Lee, Haerim (sdsd2586@naver.com (J.K.)) ,  Lim, Jonghoon (lhr6515@naver.com (H.L.)) ,  Oh, Jaeho (tbvjwhdtlsdl@naver.com (J.L.)) ,  Shin, Soon Shik (kelberoth30@naver.com (J.O.)) ,  Yoon, Michung (Department of Biomedical Engineering, Mokwon University, Daejeon 35349, Korea)

Abstract AI-Helper 아이콘AI-Helper

Similar to neoplastic tissues, growth and development of adipose tissue are thought to be angiogenesis-dependent. Since visceral adipose tissue (VAT) is associated with development and progression of nonalcoholic fatty liver disease (NAFLD), we hypothesized that angiogenesis inhibition would attenua...

주제어

참고문헌 (45)

  1. 1. Folkman J. Tumor angiogenesis Adv. Cancer Res. 1985 43 175 203 2581424 

  2. 2. Celletti FL. Waugh J.M. Amabile P.G. Brendolan A. Hilfiker P.R. Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression Nat. Med. 2001 7 425 429 10.1038/86490 11283668 

  3. 3. Ferrara N. Davis-Smyth T. The biology of vascular endothelial growth factor Endocr. Rev. 1997 18 4 25 10.1210/edrv.18.1.0287 9034784 

  4. 4. Crandall D.L. Hausman G.J. Kral J.G. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives Microcirculation 1997 4 211 232 10.3109/10739689709146786 9219215 

  5. 5. Hobson B. Denekamp J. Endothelial proliferation Endothelial proliferation in tumours and normal tissues: Continuous labelling studies Br. J. Cancer 1984 49 405 413 10.1038/bjc.1984.66 6201181 

  6. 6. Bouloumié A. Lolmède K. Sengenès C. Galitzky J. Lafontan M. Angiogenesis in adipose tissue Ann. Endocrinol. 2002 63 91 95 

  7. 7. Kim M.Y. Park B.Y. Lee H.S. Park E.K. Hahm J.C. Lee J. Hong Y. Choi S. Park D. Lee H. The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice Int. J. Obes. 2010 34 820 830 10.1038/ijo.2010.13 20179671 

  8. 8. Dowman J.K. Tomlinson J.W. Newsome P.N. Pathogenesis of non-alcoholic fatty liver disease QJM 2010 103 71 83 10.1093/qjmed/hcp158 19914930 

  9. 9. Alwahsh S.M. Dwyer B.J. Forbes S. Thiel D.H. Lewis P.J. Ramadori G. Insulin production and resistance in different models of diet-inducedobesity and metabolic syndrome Int. J. Mol. Sci. 2017 18 E285 10.3390/ijms18020285 28134848 

  10. 10. Van der Poorten D. Milner K.L. Hui J. Hodge A. Trenell M.I. Kench J.G. London R. Peduto T. Chisholm D.J. George J. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease Hepatology 2008 48 449 457 10.1002/hep.22350 18627003 

  11. 11. Jun D.W. Han J.H. Kim S.H. Jang E.C. Kim N.I. Lee J.S. Song M.H. Kim S.H. Jo Y.J. Park Y.S. Association between low thigh fat and non-alcoholic fatty liver disease J. Gastroenterol. Hepatol. 2008 23 888 893 10.1111/j.1440-1746.2008.05330.x 18466289 

  12. 12. Yu S.J. Kim W. Kim D. Yoon J.H. Lee K. Kim J.H. Cho E.J. Lee J.H. Kim H.Y. Kim Y.J. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Medicine 2015 94 e2159 10.1097/MD.0000000000002159 26632897 

  13. 13. Mulder P. Morrison M.C. Wielinga P.Y. van Duyvenvoorde W. Kooistra T. Kleemann R. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity Int. J. Obes. 2016 40 675 684 10.1038/ijo.2015.226 26499443 

  14. 14. Cancello R. Tordjman J. Poitou C. Guilhem G. Bouillot J.L. Hugol D. Coussieu C. Basdevant A. Bar Hen A. Bedossa P. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 2006 55 1554 1561 10.2337/db06-0133 16731817 

  15. 15. Smith U. Abdominal obesity: A marker of ectopic fat accumulation J. Clin. Investig. 2015 125 1790 1792 10.1172/JCI81507 25932676 

  16. 16. Duval C. Thissen U. Keshtkar S. Accart B. Stienstra R. Boekschoten M.V. Roskams T. Kersten S. Müller M. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice Diabetes 2010 59 3181 3191 10.2337/db10-0224 20858684 

  17. 17. Shin S.S. Yoon M. The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation Pharm. Biol. 2012 50 1261 1268 10.3109/13880209.2012.666982 22870903 

  18. 18. Ishimoto T. Lanaspa M.A. Rivard C.J. Roncal-Jimenez C.A. Orlicky D.J. Cicerchi C. McMahan R.H. Abdelmalek M.F. Rosen H.R. Jackman M.R. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase Hepatology 2013 58 1632 1643 10.1002/hep.26594 23813872 

  19. 19. Savard C. Tartaglione E.V. Kuver R. Haigh W.G. Farrell G.C. Subramanian S. Chait A. Yeh M.M. Quinn L.S. Ioannou G.N. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis Hepatology 2013 57 81 92 10.1002/hep.25789 22508243 

  20. 20. Alwahsh S.M. Xu M. Schultze F.C. Wilting J. Mihm S. Raddatz D. Ramadori G. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats PLoS ONE 2014 9 e104220 10.1371/journal.pone.0104220 25101998 

  21. 21. Park B.Y. Lee H. Woo S. Yoon M. Kim J. Hong Y. Lee H.S. Park E.K. Hahm J.C. Kim J.W. Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis PLoS ONE 2015 10 e0141612 10.1371/journal.pone.0141612 26599360 

  22. 22. Woo S. Yoon M. Kim J. Hong Y. Kim M.Y. Shin S.S. Yoon M. The anti-angiogenic herbal extract from Melissa officinalis inhibits adipogenesis in 3T3-L1 adipocytes and suppresses adipocyte hypertrophy in high fat diet-induced obese C57BL/6J mice J. Ethnopharmacol. 2016 178 238 250 10.1016/j.jep.2015.12.015 26702505 

  23. 23. Rupnick M.A. Panigrahy D. Zhang C. Dallabrida S.M. Lowell B.B. Langer R. Folkman M.J. Adipose tissue mass can be regulated through the vasculature Proc. Natl. Acad. Sci. USA 2002 99 10730 10735 10.1073/pnas.162349799 12149466 

  24. 24. Bråkenhielm E. Cao R. Gao B. gelin B. Cannon B. Parini P. Cao Y. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice Circ. Res. 2004 94 1579 1588 10.1161/01.RES.0000132745.76882.70 15155527 

  25. 25. Després J.P. Lemieux I. Abdominal obesity and metabolic syndrome Nature 2006 444 881 887 10.1038/nature05488 17167477 

  26. 26. Jeong S. Yoon M. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice Exp. Mol. Med. 2009 41 397 405 10.3858/emm.2009.41.6.045 19322024 

  27. 27. Cao Y. Angiogenesis modulates adipogenesis and obesity J. Clin. Investig. 2007 117 2362 2368 10.1172/JCI32239 17786229 

  28. 28. Diehl A.M. Hepatic complications of obesity Gastroenterol. Clin. N. Am. 2005 34 45 61 10.1016/j.gtc.2004.12.012 15823438 

  29. 29. Westerbacka J. Cornér A. Tiikkainen M. Tamminen M. Vehkavaara S. Häkkinen A.M. Fredriksson J. Yki-Järvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: Implications for sex differences in markers of cardiovascular risk Diabetologia 2004 47 1360 1369 10.1007/s00125-004-1460-1 15309287 

  30. 30. Blüher M. Adipose tissue dysfunction in obesity Exp. Clin. Endocrinol. Diabetes 2009 117 241 250 10.1055/s-0029-1192044 19358089 

  31. 31. Reddy J.K. Rao M.S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am. J. Physiol. Gastrointest. Liver Physiol. 2006 290 G852 G858 10.1152/ajpgi.00521.2005 16603729 

  32. 32. Yoon M. The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions Pharmacol. Res. 2009 60 151 159 10.1016/j.phrs.2009.02.004 19646654 

  33. 33. Donnelly K.L. Smith C.I. Schwarzenberg S.J. Jessurun J. Boldt M.D. Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J. Clin. Investig. 2005 115 1343 1351 10.1172/JCI23621 15864352 

  34. 34. Weisberg S.P. McCann D. Desai M. Rosenbaum M. Leibel R.L. Ferrante A.W. Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Investig. 2003 112 1796 1808 10.1172/JCI200319246 14679176 

  35. 35. Cancello R. Henegar C. Viguerie N. Taleb S. Poitou C. Rouault C. Coupaye M. Pelloux V. Hugol D. Bouillot J.L. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 2005 54 2277 2286 10.2337/diabetes.54.8.2277 16046292 

  36. 36. Cinti S. Mitchell G. Barbatelli G. Murano I. Ceresi E. Faloia E. Wang S. Fortier M. Greenberg A.S. Obin M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J. Lipid. Res. 2005 46 2347 2355 10.1194/jlr.M500294-JLR200 16150820 

  37. 37. Spruss A. Kanuri G. Wagnerberger S. Haub S. Bischoff S.C. Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 2009 50 1094 1104 10.1002/hep.23122 19637282 

  38. 38. De Minicis S. Rychlicki C. Agostinelli L. Saccomanno S. Candelaresi C. Trozzi L. Mingarelli E. Facinelli B. Magi G. Palmieri C. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice Hepatology 2014 59 1738 1749 10.1002/hep.26695 23959503 

  39. 39. Alwahsh S.M. Xu M. Seyhan H.A. Ahmad S. Mihm S. Ramadori G. Schultze F.C. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver World J. Gastroenterol. 2014 20 1807 1821 10.3748/wjg.v20.i7.1807 24587658 

  40. 40. Jabri M.A. Sakly M. Marzouki L. Sebai H. Chamomile ( Matricaria recutita L.) decoction extract inhibits in vitro intestinal glucose absorption and attenuates high fat diet-induced lipotoxicity and oxidative stress Biomed. Pharmacother. 2017 87 153 159 10.1016/j.biopha.2016.12.043 28056419 

  41. 41. Cui B. Liu S. Lin X. Wang J. Li S. Wang Q. Li S. Effects of Lycium barbarum aqueous and ethanol extracts on high-fat-diet induced oxidative stress in rat liver tissue Molecules 2011 16 9116 9128 10.3390/molecules16119116 22045040 

  42. 42. Alwahsh S.M. Gebhardt R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD) Arch. Toxicol. 2017 91 1545 1563 10.1007/s00204-016-1892-7 27995280 

  43. 43. Cakir M. Akbulut U.E. Okten A. Association between Adherence to the Mediterranean Diet and Presence of Nonalcoholic Fatty Liver Disease in Children Child Obes. 2016 12 279 285 10.1089/chi.2015.0197 26871614 

  44. 44. Oh S. So R. Shida T. Matsuo T. Kim B. Akiyama K. Isobe T. Okamoto Y. Tanaka K. Shoda J. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease Sci. Rep. 2017 7 43029 10.1038/srep43029 28223710 

  45. 45. Hsu W.F. Sheen L.Y. Lin H.J. Chang H.H. A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease Evid. Based Complement. Alternat. Med. 2016 2016 6491420 10.1155/2016/6491420 27872651 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로